# Albor Diagnostics Laboratories LTDA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/albor-diagnostics-laboratories-ltda

- Industry: Healthcare IT
- Headquarters: Sao Paulo, Brazil
- Website: www.isalab.com.br
- Total disclosed funding: $14M
- Latest round: Series A (Aug 9, 2022)
- Investors on record: 8

## About

Albor Diagnostics Laboratories LTDA specializes in at-home healthcare solutions, focusing on laboratory testing and vaccination services to enhance patient convenience and accessibility in Brazil.Founded in 2020, Albor Diagnostics Laboratories LTDA is based in Sao Paulo, Brazil, where it provides innovative healthcare solutions. The company was established by David Pares and Fernando Pares, with Fabricio Muniz serving as the CEO. The company has successfully raised BRL 60 million in its Series A funding round on August 9, 2022, with participation from several investors including Vox Capital and Kortex Ventures. The company has completed a total of 3 deals to date.ISA Lab specializes in providing at-home healthcare solutions, particularly focusing on laboratory testing and vaccination services. Their core offerings include a wide range of laboratory tests, COVID-19 testing, and vaccinations, all designed to deliver convenience and comfort for patients by allowing them to remain in their homes. The service mechanism is streamlined: patients select their health insurance plan or indicate that they will pay privately, submit their medical requests, and schedule an appointment for sample collection. The company caters to a diverse clientele, including individuals with health insurance from various Brazilian providers and those seeking private care. ISA Lab operates primarily in the Brazilian market, aiming to enhance patient access to health services without the need for travel or prolonged waiting times.ISA Lab's revenue model is based on direct transactions with consumers who require medical testing and vaccination services. Clients can schedule appointments through the company's online portal, specifying their health insurance details or opting for private services. The transaction structure involves a straightforward pricing plan where patients can pay for individual tests and services as needed. The company collaborates with a wide array of health insurance providers, which facilitates a smooth billing process for insured patients. Upon completion of the services, clients receive their test results via email, further enhancing the efficiency of the service delivery. The flagship offerings include laboratory tests and COVID-19 testing, which do not necessarily require a medical prescription, allowing for broader accessibility among users.In August 2022, Albor Diagnostics Laboratories LTDA raised BRL 60 million in Series A funding co-led by new investors Vox Capital and Kortex Ventures, with participation from other new investors Endeavor Scale-up Ventures, FIR Capital, and YAYA Capital. The funding is designated to increase its global footprint by entering new cities and offering more domestic services. The company plans to expand its operations into additional markets within Brazil to enhance accessibility to its offerings.

## Funding rounds

- Series A, Aug 9, 2022, $12M — FIR Capital, Vox Capital, Canary, MatterScale Ventures, Kortex Ventures, Endeavor Scale-up Ventures, YAYA Capital
- Series A, Sep 10, 2021, $2.5M — Canary, Norte Ventures, MatterScale Ventures

## Investors

- Canary (https://capitalatlas.ai/funds/canary) — Series A
- Norte Ventures (https://capitalatlas.ai/funds/norte-ventures) — Series A
- MatterScale Ventures (https://capitalatlas.ai/funds/matterscale-ventures) — Series A
- FIR Capital (https://capitalatlas.ai/funds/fir-capital) — Series A
- Vox Capital (https://capitalatlas.ai/funds/vox-capital) — Series A
- Kortex Ventures (https://capitalatlas.ai/funds/kortex-ventures) — Series A
- Endeavor Scale-up Ventures (https://capitalatlas.ai/funds/endeavor-scale-up-ventures) — Series A
- YAYA Capital — Series A